CLINICAL_TRIALS
trial_result
· 2019-03-04
Clinical Trial Update: Transition From Alendronate to Romosozumab (AMG 785) [Phase 1]
Summary
Phase 1 trial update describing transition from alendronate to romosozumab (AMG 785) in osteoporosis; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED | Results posted: 2019-03-04